Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Cirrhosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03193502
What this trial is testing

Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis

Who this might be right for
Portal Vein Thrombosis
Sherief Abd-Elsalam 40
Large-scale testing (Phase 3)Study completedNCT02023099
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 363
Not applicableLooking for participantsNCT07469319
What this trial is testing

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Cirrhosis
University of Aarhus 617
Not applicableUnknownNCT06147934
What this trial is testing

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD

Who this might be right for
Liver FibrosisLiver Cirrhosis
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Testing effectiveness (Phase 2)Study completedNCT06675929
What this trial is testing

Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Who this might be right for
Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
Boehringer Ingelheim 28
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Testing effectiveness (Phase 2)Study completedNCT01409356
What this trial is testing

Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis

Who this might be right for
Compensated CirrhosisObesity
Hospital Clinic of Barcelona 60
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Not applicableStudy completedNCT03053180
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

Who this might be right for
Chronic Hepatitis C
AbbVie 60
Large-scale testing (Phase 3)Study completedNCT01973049
What this trial is testing

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 202
Not applicableStudy completedNCT02508298
What this trial is testing

Surrogate Markers of Portal Pressure

Who this might be right for
Portal HypertensionCirrhosis
VA Connecticut Healthcare System 41
Not applicableActive Not RecruitingNCT04383951
What this trial is testing

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Indiana University 40
Not applicableUnknownNCT02325622
What this trial is testing

Relationships Between Mean Plasma Glucose and HbA1c in Cirrhotic Patients With Hepatogenous Diabetes

Who this might be right for
Liver CirrhosisDiabetes Mellitus
Yonsei University 48
Not applicableUnknownNCT04975477
What this trial is testing

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Not applicableUnknownNCT05538546
What this trial is testing

Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients

Who this might be right for
CirrhosisVaricesNon-invasive Evaluation
Huashan Hospital 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Not applicableUnknownNCT03144700
What this trial is testing

The Natural History and Prognostic Factors of Compensated Cirrhosis.

Who this might be right for
Compensated Cirrhosis
Institute of Liver and Biliary Sciences, India 166
Large-scale testing (Phase 3)Looking for participantsNCT07701993
What this trial is testing

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
GlaxoSmithKline 1,740
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Testing effectiveness (Phase 2)Study completedNCT04210245
What this trial is testing

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 160
Next Page